Involvement of serum retinoids and Leiden mutation in patients with esophageal, gastric, liver, pancreatic, and colorectal cancers in Hungary

Table 1 Patients with different gastrointestinal tumors

		Number of patients
Types of tumors	Male	Female	Total	Histology
Esophageal	8 (60±10 yr)1	–	8	Planocellular carcinoma
Gastric	16 (64±12 yr)1	5 (68±10 yr)1	21	Adenocarcinoma
Liver	8 (60±8 yr)1	7 (57±13 yr)1	15	Hepatocellular carcinoma
Pancreas	6 (56±11 yr)1	4 (63±9 yr)1	10	Adenocarcinoma
Colorectal	30 (66±10 yr)1	23 (65±11 yr)1	53	Adenocarcinoma
In situ carcinoma in colon polyps	4 (60±5 yr)1	5 (61±5 yr)1	9	Adenocarcinoma
Total	70	37	107
Healthy subjects	29 (50±12 yr)1	28 (49±10 yr)1	57

600 blood donors (healthy controls) for Leiden mutation study.

¹Age of patients (mean±SD).